Significant findings
At baseline (hospital discharge) there were sex-related differences: women were significantly older (71.4 versus 63.2 years; P<0.001) and were more likely to have a history of heart failure and hypertension. Men were more likely to have a history of MI and experience arrhythmias and Q-wave infarction, while women suffered more heart failure and heart block. By 2 years after discharge, 1,577 patients had died (28.9% of the women versus 19.6% of men); this translated into a hazard ratio for women of 1.47 (95% confidence interval [CI] 1.35-1.61). However, further analysis revealed that this increased risk was only applicable to younger women (<60 years), with older (>60 years) women having a similar prognosis to older men. Sex differences in mortality rate decreased with advancing age, and, among the oldest patients, women tended to have lower mortality rates than men. Results were consistent when examined in terms of risk difference. The absolute risk for women compared with men was highest in patients younger than 60 years of age, while the absolute risk was lower for women among patients at least 80 years of age.
When the authors adjusted for age in a Cox proportional hazards model, it seemed to explain the overall sex difference in 2 year mortality rate, yielding a hazard ratio of 1.00 (95% CI 0.90-1.12). However, when the interaction between sex and age was included in the model, it was found to be statistically significant. For every 10-year decrease in patients' age, hazards of death in women increased 13.1% (95% CI 3.1%-23.9%) compared with men. When the multivariable-adjusted results were expressed in terms of absolute risk difference, an increased mortality rate among women compared with men was found only among patients younger than 60 years of age. Among older patients, women had a lower absolute risk for death than men.
Comments
The reasons for the sex differential remain unclear. The most likely are genetic, hormonal, or inflammatory factors. An accompanying editorial (see Additional information) points out that, although endogenous estrogens are known to be cardioprotective, some studies have shown increased levels of Creactive protein with exogenous hormone therapy, suggesting that this common treatment used primarily by middle-aged women has potential pro-inflammatory effects. The editorial concludes: 'While researchers strive to confirm the age-sex interaction and to understand its mechanisms, practicing physicians can ensure that interventions of proven value, including effective cardiac drugs, antidepressants, smoking cessation, and cardiac rehabilitation, are consistently provided to all eligible patients after myocardial infarction.'
